Direxion Daily S&P Biotech Bull 3X ETF
LABU
20 hedge funds and large institutions have $25.3M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 7 closing their positions.
0% more funds holding
Funds holding: 20 → 20 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
1.27% less ownership
Funds ownership: 4.77% → 3.5% (-1.3%)
31% less call options, than puts
Call options by funds: $108M | Put options by funds: $157M
47% less capital inflows, than outflows
Capital inflows: $6.85M | Capital outflows: $12.8M
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.66M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$2.2M |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$1.21M |
| 4 |
Flow Traders U.S.
New York
|
+$204K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
+$188K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRT Financial
New York
|
-$4.65M |
| 2 |
Tower Research Capital (TRC)
New York
|
-$2.36M |
| 3 |
Harvest Investment Services
Oakbrook Terrace,
Illinois
|
-$2.04M |
| 4 |
Hellman Jordan Management Company
Quincy,
Massachusetts
|
-$1.2M |
| 5 |
Morgan Stanley
New York
|
-$928K |
LABU Hedge Fund Activity: Q4 2020 in Review
20 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2020, worth a combined $25.3M — up 37% from $18.4M a quarter earlier.
Fund positioning in LABU was balanced in Q4 2020: 7 funds opened new positions, 7 closed out, 3 added to existing stakes and 8 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $2.66M. The largest seller was HRT Financial, cutting an estimated $4.65M.
- 20 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $25.3M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2020, up 37% quarter-over-quarter.
- 7 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2020 and 7 closed out, a net change of 0 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2020 was Susquehanna International Group, an estimated $2.66M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2020 was HRT Financial, an estimated $4.65M sold.
Based on aggregated 13F filings for Q4 2020.